Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

"Purple toes" syndrome

C S Lebsack, R T Weibert

    Postgraduate Medicine
    |May 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    A 73-year-old woman developed purple toes and a skin rash while taking warfarin sodium. These symptoms resolved after discontinuing the anticoagulant medication, indicating a drug-induced reaction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillation.

    The Annals of pharmacotherapy·2000
    Same author

    Correction of excessive anticoagulation with low-dose oral vitamin K1.

    Annals of internal medicine·1997
    Same author

    The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods.

    Annals of internal medicine·1994
    Same author

    Oral anticoagulant therapy in patients undergoing dental surgery.

    Clinical pharmacy·1992
    Same author

    Evaluation of a capillary whole-blood prothrombin time measurement system.

    Clinical pharmacy·1989
    Same author

    Effect of erythromycin in patients receiving long-term warfarin therapy.

    Clinical pharmacy·1989
    Same journal

    CV risk: if you aren't testing ACR, you aren't seeing the full picture.

    Postgraduate medicine·2026
    Same journal

    Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

    Postgraduate medicine·2026
    Same journal

    Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

    Postgraduate medicine·2026
    Same journal

    Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

    Postgraduate medicine·2026
    Same journal

    The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

    Postgraduate medicine·2026
    Same journal

    Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

    Postgraduate medicine·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Pharmacology
    • Cardiology

    Background:

    • Warfarin sodium is a common anticoagulant used to prevent stroke in patients with atrial fibrillation.
    • Antiarrhythmic agents are frequently prescribed alongside warfarin for cardiovascular conditions.

    Observation:

    • A 73-year-old female patient presented with "purple toes" syndrome and a generalized skin eruption.
    • The patient was concurrently undergoing treatment with warfarin sodium and antiarrhythmic agents following a stroke.

    Findings:

    • The "purple toes" syndrome and skin rash were strongly correlated with warfarin sodium administration.
    • Cessation of warfarin sodium led to the gradual resolution of both the rash and the foot discoloration.

    Implications:

    Related Experiment Videos

    • This case highlights a rare but significant adverse reaction to warfarin sodium, emphasizing the need for vigilant monitoring.
    • Clinicians should consider warfarin-induced skin reactions in patients presenting with similar symptoms.
    • Early recognition and discontinuation of the offending agent are crucial for managing this side effect.